What is it about?
Antiplatelet therapies in type 2 diabetes mellitus patients after PCI
Featured Image
Why is it important?
diabetic patients often have platelet dysfunction. Therefore, after coronary intervention, dual antiplatelet therapy may not be sufficient in such patients. Triple antiplatelet therapy is a better choice.
Perspectives
This research is about the selection of a better antiplatelet regimen in type 2 diabetic patients after percutaneous coronary intervention.
Dr Pravesh Kumar Bundhun
first affiliated hospital of Guangxi Medical University
Read the Original
This page is a summary of: Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials, BMC Cardiovascular Disorders, October 2015, Springer Science + Business Media,
DOI: 10.1186/s12872-015-0114-1.
You can read the full text:
Resources
Contributors
The following have contributed to this page
